Histone deacetylases inhibitors (HDACis) as novel therapeutic application in various clinical diseases

被引:68
作者
Qiu, Xiaoyan [1 ]
Xiao, Xiong [1 ]
Li, Nan [1 ]
Li, Yuemin [1 ]
机构
[1] Southwest Univ, Sch Anim Sci & Technol, 2 Tian Sheng St, Chongqing 400715, Peoples R China
基金
中国国家自然科学基金;
关键词
HDACi; Brain disorders; Cancer; Endometriosis; Cell reprogramming; SUBEROYLANILIDE HYDROXAMIC ACID; SPINAL MUSCULAR-ATROPHY; CELL NUCLEAR TRANSFER; RUBINSTEIN-TAYBI-SYNDROME; IN-VITRO DEVELOPMENT; EXPERIMENTALLY-INDUCED ENDOMETRIOSIS; TRANSGENIC MOUSE MODEL; LONG-TERM-MEMORY; PHASE-II TRIAL; PROTECTS DOPAMINERGIC-NEURONS;
D O I
10.1016/j.pnpbp.2016.09.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Accumulating evidence suggests that histone hypoacetylation which is partly mediated by histone deacetylase (HDAC), plays a causative role in the etiology of various clinical disorders such as cancer and central nervous diseases. HDAC inhibitors (HDACis) are natural or synthetic small molecules that can inhibit the activities of HDACs and restore or increase the level of histone acetylation, thus may represent the potential approach to treating a number of clinical disorders. This manuscript reviewed the progress of the most recent experimental application of HDACis as novel potential drugs or agents in a large number of clinical disorders including various brain disorders including neurodegenerative and neurodevelopmental cognitive disorders and psychiatric diseases like depression, anxiety, fear and schizophrenia, and cancer, endometriosis and cell reprogramming in somatic cell nuclear transfer in human and animal models of disease, and concluded that HDACis as potential novel therapeutic agents could be used alone or in adjunct to other pharmacological agents in various clinical diseases. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:60 / 72
页数:13
相关论文
共 283 条
[91]   Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition [J].
Hauke, Jan ;
Riessland, Markus ;
Lunke, Sebastian ;
Eyuepoglu, Ilker Y. ;
Bluemcke, Ingmar ;
El-Osta, Assam ;
Wirth, Brunhilde ;
Hahnen, Eric .
HUMAN MOLECULAR GENETICS, 2009, 18 (02) :304-317
[92]   Progressive decrease in chaperone protein levels in a mouse model of Huntington's disease and induction of stress proteins as a therapeutic approach [J].
Hay, DG ;
Sathasivam, K ;
Tobaben, S ;
Stahl, B ;
Marber, M ;
Mestril, R ;
Mahal, A ;
Smith, DL ;
Woodman, B ;
Bates, GP .
HUMAN MOLECULAR GENETICS, 2004, 13 (13) :1389-1405
[93]   Repeated valproate treatment facilitates fear extinction under specific stimulus conditions [J].
Heinrichs, Stephen C. ;
Leite-Morrisa, Kimberly A. ;
Rasmusson, Ann M. ;
Kaplan, Gary B. .
NEUROSCIENCE LETTERS, 2013, 552 :108-113
[94]   Histone deacetylases-an important class of cellular regulators with a variety of functions [J].
Hildmann, Christian ;
Riester, Daniel ;
Schwienhorst, Andreas .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2007, 75 (03) :487-497
[95]   Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 glioblastoma cells [J].
Hisaoka, K ;
Nishida, A ;
Koda, T ;
Miyata, M ;
Zensho, H ;
Morinobu, S ;
Ohta, M ;
Yamawaki, S .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (01) :25-34
[96]   Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease [J].
Hockly, E ;
Richon, VM ;
Woodman, B ;
Smith, DL ;
Zhou, XB ;
Rosa, E ;
Sathasivam, K ;
Ghazi-Noori, S ;
Mahal, A ;
Lowden, PAS ;
Steffan, JS ;
Marsh, JL ;
Thompson, LM ;
Lewis, CM ;
Marks, PA ;
Bates, GP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :2041-2046
[97]   The effects of repeated social defeat on long-term depressive-like behavior and short-term histone modifications in the hippocampus in male Sprague-Dawley rats [J].
Hollis, Fiona ;
Wang, Hui ;
Dietz, David ;
Gunjan, Akash ;
Kabbaj, Mohamed .
PSYCHOPHARMACOLOGY, 2010, 211 (01) :69-77
[98]   Effects of Histone Deacetylase Inhibitor Oxamflatin on In Vitro Porcine Somatic Cell Nuclear Transfer Embryos [J].
Hou, Liming ;
Ma, Fanhua ;
Yang, Jinzeng ;
Riaz, Hasan ;
Wang, Yongliang ;
Wu, Wangjun ;
Xia, Xiaoliang ;
Ma, Zhiyuan ;
Zhou, Ying ;
Zhang, Lin ;
Ying, Wenqin ;
Xu, Dequan ;
Zuo, Bo ;
Ren, Zhuqing ;
Xiong, Yuanzhu .
CELLULAR REPROGRAMMING, 2014, 16 (04) :253-265
[99]   Identification of novel isoform-selective inhibitors within class I histone deacetylases [J].
Hu, ED ;
Dul, E ;
Sung, CM ;
Chen, ZX ;
Kirkpatrick, R ;
Zhang, GF ;
Johanson, K ;
Liu, RG ;
Lago, A ;
Hofmann, G ;
Macarron, R ;
de los Frailes, M ;
Perez, P ;
Krawiec, J ;
Winkler, J ;
Jaye, M .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (02) :720-728
[100]  
Hu SW, 2012, J ANIM VET ADV, V11, P1868